1. Woyach J, Shah M. New therapeutic advances in the management of progressive thyroid cancer. Endocr Relat Cancer. 2009. 02. 13. [Epub ahead of print].
2. Sherman SI. Advances in chemotherapy of differentiated epithelial and medullary thyroid cancers. J Clin Endocrinol Metab. 2009. 94:1493–1499.
3. Shin HW, Jang HW, Kim KS, Lee JI, Kim SW, Min YK, Lee MS, Lee MK, Kim KW, Chung JH. Search for materials that influence human medullary thyroid carcinoma cell proliferation. J Korean Endocr Soc. 2009. 24:93–99.
4. Venkateswaran A, Marsee DK, Green SH, Jhiang SM. Forskolin, 8-Br-3',5'-cyclic adenosine 5'-monophosphate, and catalytic protein kinase A expression in the nucleus increase radioiodide uptake and sodium/iodide symporter protein levels in RET/PTC1-expressing cells. J Clin Endocrinol Metab. 2004. 89:6168–6172.
5. Frendo JL, Delage-Mourroux R, Cohen R, Pichaud F, Pidoux E, Guliana JM, Jullienne A. Calcitonin receptor mRNA expression in TT cells: effect of dexamethasone. Mol Cell Endocrinol. 1998. 139:37–43.
6. Birnbaum RS, Bertelsen AH, Roos BA. Glucocorticoid regulation of amidating enzyme in a neoplastic C-cell line. Mol Cell Endocrinol. 1989. 61:109–116.
7. Mertens PR, Goretzki PE, Keck E. cAMP-synthesis in a medullary thyroid carcinoma cell line: response to adrenergic agents and prostaglandines. Exp Clin Endocrinol Diabetes. 1999. 107:488–495.
8. Meyer EL, Goemann IM, Dora JM, Wagner MS, Maia AL. Type 2 iodothyronine deiodinase is highly expressed in medullary thyroid carcinoma. Mol Cell Endocrinol. 2008. 289:16–22.
9. de Bruin C, Feelders RA, Waaijers AM, van Koetsveld PM, Sprij-Mooij DM, Lamberts SW, Hofland LJ. Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro. J Mol Endocrinol. 2009. 42:47–56.
10. Cote GJ, Palmer WN, Leonhart K, Leong SS, Gagel RF. The regulation of somatostatin production in human medullary thyroid carcinoma cells by dexamethasone. J Biol Chem. 1986. 261:12930–12935.
11. Reubi JC. Targeting CCK receptors in human cancers. Curr Top Med Chem. 2007. 7:1239–1242.
12. Machens A, Hauptmann S, Dralle H. Medullary thyroid cancer responsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissemination? J Clin Endocrinol Metab. 2008. 93:2234–2238.